126 related articles for article (PubMed ID: 24449560)
1. Response to re: TG13 antimicrobial therapy for acute cholangitis and cholecystitis.
Gomi H; Solomkin JS
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):E11. PubMed ID: 24449560
[No Abstract] [Full Text] [Related]
2. Re: TG13 antimicrobial therapy for acute cholangitis and cholecystitis.
Iwata K; Doi A; Matsuo H; Takegawa H; Ohji G
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):E10. PubMed ID: 24449559
[No Abstract] [Full Text] [Related]
3. TG13 antimicrobial therapy for acute cholangitis and cholecystitis.
Gomi H; Solomkin JS; Takada T; Strasberg SM; Pitt HA; Yoshida M; Kusachi S; Mayumi T; Miura F; Kiriyama S; Yokoe M; Kimura Y; Higuchi R; Windsor JA; Dervenis C; Liau KH; Kim MH;
J Hepatobiliary Pancreat Sci; 2013 Jan; 20(1):60-70. PubMed ID: 23340954
[TBL] [Abstract][Full Text] [Related]
4. [TG13: THE UPDATED TOKYO'S CLINICAL RECOMMENDATIONS FOR TREATMENT OF AN ACUTE CHOLANGITIS AND CHOLECYSTITIS].
Usenko AY; Yareshko VG; Nichitaylo ME; Mikheyev YA; Andreyeshchev SA
Klin Khir; 2015 Oct; (10):5-10. PubMed ID: 26946649
[TBL] [Abstract][Full Text] [Related]
5. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.
Gomi H; Solomkin JS; Schlossberg D; Okamoto K; Takada T; Strasberg SM; Ukai T; Endo I; Iwashita Y; Hibi T; Pitt HA; Matsunaga N; Takamori Y; Umezawa A; Asai K; Suzuki K; Han HS; Hwang TL; Mori Y; Yoon YS; Huang WS; Belli G; Dervenis C; Yokoe M; Kiriyama S; Itoi T; Jagannath P; Garden OJ; Miura F; de Santibañes E; Shikata S; Noguchi Y; Wada K; Honda G; Supe AN; Yoshida M; Mayumi T; Gouma DJ; Deziel DJ; Liau KH; Chen MF; Liu KH; Su CH; Chan ACW; Yoon DS; Choi IS; Jonas E; Chen XP; Fan ST; Ker CG; Giménez ME; Kitano S; Inomata M; Mukai S; Higuchi R; Hirata K; Inui K; Sumiyama Y; Yamamoto M
J Hepatobiliary Pancreat Sci; 2018 Jan; 25(1):3-16. PubMed ID: 29090866
[TBL] [Abstract][Full Text] [Related]
6. Review of the Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis.
Buckman SA; Mazuski JE
JAMA Surg; 2019 Sep; 154(9):873-874. PubMed ID: 31268508
[No Abstract] [Full Text] [Related]
7. TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis.
Takada T; Strasberg SM; Solomkin JS; Pitt HA; Gomi H; Yoshida M; Mayumi T; Miura F; Gouma DJ; Garden OJ; Büchler MW; Kiriyama S; Yokoe M; Kimura Y; Tsuyuguchi T; Itoi T; Gabata T; Higuchi R; Okamoto K; Hata J; Murata A; Kusachi S; Windsor JA; Supe AN; Lee S; Chen XP; Yamashita Y; Hirata K; Inui K; Sumiyama Y;
J Hepatobiliary Pancreat Sci; 2013 Jan; 20(1):1-7. PubMed ID: 23307006
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines.
Yoshida M; Takada T; Kawarada Y; Tanaka A; Nimura Y; Gomi H; Hirota M; Miura F; Wada K; Mayumi T; Solomkin JS; Strasberg S; Pitt HA; Belghiti J; de Santibanes E; Fan ST; Chen MF; Belli G; Hilvano SC; Kim SW; Ker CG
J Hepatobiliary Pancreat Surg; 2007; 14(1):83-90. PubMed ID: 17252301
[TBL] [Abstract][Full Text] [Related]
9. TG13 management bundles for acute cholangitis and cholecystitis.
Okamoto K; Takada T; Strasberg SM; Solomkin JS; Pitt HA; Garden OJ; Büchler MW; Yoshida M; Miura F; Kimura Y; Higuchi R; Yamashita Y; Mayumi T; Gomi H; Kusachi S; Kiriyama S; Yokoe M; Lau WY; Kim MH;
J Hepatobiliary Pancreat Sci; 2013 Jan; 20(1):55-9. PubMed ID: 23307002
[TBL] [Abstract][Full Text] [Related]
10. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis.
Kimura Y; Takada T; Strasberg SM; Pitt HA; Gouma DJ; Garden OJ; Büchler MW; Windsor JA; Mayumi T; Yoshida M; Miura F; Higuchi R; Gabata T; Hata J; Gomi H; Dervenis C; Lau WY; Belli G; Kim MH; Hilvano SC; Yamashita Y
J Hepatobiliary Pancreat Sci; 2013 Jan; 20(1):8-23. PubMed ID: 23307004
[TBL] [Abstract][Full Text] [Related]
11. TG13 flowchart for the management of acute cholangitis and cholecystitis.
Miura F; Takada T; Strasberg SM; Solomkin JS; Pitt HA; Gouma DJ; Garden OJ; Büchler MW; Yoshida M; Mayumi T; Okamoto K; Gomi H; Kusachi S; Kiriyama S; Yokoe M; Kimura Y; Higuchi R; Yamashita Y; Windsor JA; Tsuyuguchi T; Gabata T; Itoi T; Hata J; Liau KH;
J Hepatobiliary Pancreat Sci; 2013 Jan; 20(1):47-54. PubMed ID: 23307003
[TBL] [Abstract][Full Text] [Related]
12. Response to Re: Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.
Gomi H; Okamoto K; Ukai T; Takada T
J Hepatobiliary Pancreat Sci; 2018 Jun; 25(6):E6. PubMed ID: 29878697
[No Abstract] [Full Text] [Related]
13. [Experiences in the conservative treatment of cholecystopathies and cholangiopathies].
Baumgart R
Z Allgemeinmed; 1969 Jul; 45(19):926-7. PubMed ID: 5800266
[No Abstract] [Full Text] [Related]
14. Re: Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.
Guerin O; Regimbeau JM
J Hepatobiliary Pancreat Sci; 2018 Jun; 25(6):E5. PubMed ID: 29878694
[No Abstract] [Full Text] [Related]
15. Bile and gallbladder tissue concentrations of moxifloxacin in patients with acute cholecystitis.
Stein GE; Smith CL; Peloquin CA; Mosher B; Dybas L; Kepros JP
Ann Pharmacother; 2010; 44(7-8):1346-7. PubMed ID: 20551298
[No Abstract] [Full Text] [Related]
16. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).
Yokoe M; Hata J; Takada T; Strasberg SM; Asbun HJ; Wakabayashi G; Kozaka K; Endo I; Deziel DJ; Miura F; Okamoto K; Hwang TL; Huang WS; Ker CG; Chen MF; Han HS; Yoon YS; Choi IS; Yoon DS; Noguchi Y; Shikata S; Ukai T; Higuchi R; Gabata T; Mori Y; Iwashita Y; Hibi T; Jagannath P; Jonas E; Liau KH; Dervenis C; Gouma DJ; Cherqui D; Belli G; Garden OJ; Giménez ME; de Santibañes E; Suzuki K; Umezawa A; Supe AN; Pitt HA; Singh H; Chan ACW; Lau WY; Teoh AYB; Honda G; Sugioka A; Asai K; Gomi H; Itoi T; Kiriyama S; Yoshida M; Mayumi T; Matsumura N; Tokumura H; Kitano S; Hirata K; Inui K; Sumiyama Y; Yamamoto M
J Hepatobiliary Pancreat Sci; 2018 Jan; 25(1):41-54. PubMed ID: 29032636
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial therapy of acute purulent cholangitis].
Bogomolova NS; Tsatsnidi KN; Shervashidze GG; Drachennikova AA; Vinogradova LN
Khirurgiia (Mosk); 1987 Feb; (2):58-63. PubMed ID: 3560739
[No Abstract] [Full Text] [Related]
18. New developments and concepts in antimicrobial therapy for intra-abdominal infections.
Younes Z; Johnson DA
Curr Gastroenterol Rep; 2000 Aug; 2(4):277-82. PubMed ID: 10981024
[TBL] [Abstract][Full Text] [Related]
19. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis.
Mayumi T; Okamoto K; Takada T; Strasberg SM; Solomkin JS; Schlossberg D; Pitt HA; Yoshida M; Gomi H; Miura F; Garden OJ; Kiriyama S; Yokoe M; Endo I; Asbun HJ; Iwashita Y; Hibi T; Umezawa A; Suzuki K; Itoi T; Hata J; Han HS; Hwang TL; Dervenis C; Asai K; Mori Y; Huang WS; Belli G; Mukai S; Jagannath P; Cherqui D; Kozaka K; Baron TH; de Santibañes E; Higuchi R; Wada K; Gouma DJ; Deziel DJ; Liau KH; Wakabayashi G; Padbury R; Jonas E; Supe AN; Singh H; Gabata T; Chan ACW; Lau WY; Fan ST; Chen MF; Ker CG; Yoon YS; Choi IS; Kim MH; Yoon DS; Kitano S; Inomata M; Hirata K; Inui K; Sumiyama Y; Yamamoto M
J Hepatobiliary Pancreat Sci; 2018 Jan; 25(1):96-100. PubMed ID: 29090868
[TBL] [Abstract][Full Text] [Related]
20. Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia.
Uno S; Hase R; Kobayashi M; Shiratori T; Nakaji S; Hirata N; Hosokawa N
Int J Infect Dis; 2017 Feb; 55():81-85. PubMed ID: 28027992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
